共 160 条
[1]
Boellaard R(2015)FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Eur J Nucl Med Mol Imaging 42 328-354
[2]
Delgado-Bolton R(2006)Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0 J Nucl Med 47 885-895
[3]
Oyen WJG(1999)Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 61-77
[4]
GiammarileF Tatsch K(2002)Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment Am J Roentgenol 179 1337-1343
[5]
Eschner W(2012)Prospective study of 2-[18F] fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study J Clin Oncol 30 1274-1279
[6]
Delbeke D(2010)Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer Eur J Radiol 73 294-299
[7]
Coleman RE(2010)The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques EJSO 36 387-392
[8]
Guiberteau MJ(2011)Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer Eur J Nucl Med Mol Imaging 38 293-301
[9]
Brown ML(2011)FDG-PET/CT in the diagnosis of recurrent breast cancer Acta Radiol 53 1-5
[10]
Royal HD(2012)Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma Nucl Med Commun 33 591-596